Skip to Main Content
TRC_PLH
Menu
    • Products
      • CriticalPoint
      • Hospital Pharmacist's Letter
      • Hospital Pharmacy Technician's Letter
      • Learning Management Portal
      • NatMed Advisor
      • NatMed Pro
      • NetCE All Access
      • Pharmacist's Letter
      • Pharmacist's Letter Canada
      • Pharmacy Technician's Letter
      • Pharmacy Technician's Letter Canada
      • Prescriber Insights
      • RxAdvanced
      • RxSelect

    Subscribe Login
  • Home
  • Letter
    • Current Issue
    • Past Issues
    • Suggest a Topic
  • Browse
    • Subject
    • Featured Charts & Graphics
    • Gender-Related Care
    • Diabetes Resources
    • Immunization Resources
    • Natural Medicines Resources
    • All Charts & Graphics
  • Podcasts
  • Charts & Graphics
    • Featured Charts & Graphics
    • Diabetes Drugs
    • Do Not Crush List
    • IV Fluid Safety
    • New Drugs
    • Opioid Dosing
    • Vancomycin Dosing
    • All Charts & Graphics >
  • CE/CME & Training
    • CE Organizer
    • Available Courses
    • My Completions
    • Live Webinars
  • Help
    • User Support
    • Contact Us

Upgrade Your Browser

We no longer support this version of your browser. We recommend that you upgrade to the latest version of Internet Explorer, Firefox, Chrome or Safari to improve your security and experience using this website.

Return to the course you were viewing

Become a smarter pharmacist in minutes! More CE, more resources, more value. Choose your Hospital Pharmacist's Letter membership and elevate your pharmacy practice today. Subscribe Now
  1. Home
  2. Browse
  3. Interactions
  4. Cardiology
  5. Antiplatelets/Anticoagulants
  6. Rivaroxaban

Rivaroxaban

  • Bone & Joint (53)
  • Cardiology (193)
    • Antiarrhythmics (58)
    • Antihypertensives (68)
    • Antiplatelets/Anticoagulants (97)
      • Apixaban (15)
      • Aspirin (29)
      • Clopidogrel (24)
      • Dabigatran (22)
      • Edoxaban (10)
      • Rivaroxaban (12)
      • Ticagrelor (10)
      • Vorapaxar (2)
      • Warfarin (73)
    • Dyslipidemia Drugs (41)
    • Other (16)
  • Dermatology (36)
  • Diabetes & Endocrinology (30)
  • Gastroenterology (47)
  • Hematology & Oncology (6)
  • Infectious Diseases (170)
  • Men's Health (5)
  • Natural Medicines / Supplements / Food Interactions (89)
  • Neurology (111)
  • Nutrition & Obesity (5)
  • Psychiatry (120)
  • Resources (34)
  • Respiratory & Allergy (17)
  • Transplant Meds (11)
  • Women's Health (36)
1 - 12 of 12 Results
Sort Results:
  • Title: Ascending (A-Z)
  • Date: Newest First
  • Date: Oldest First
Chart: Drug Interactions: Cytochrome P450 (CYP), P-glycoprotein, and More
May 2024
Article: Recognize Which DOAC Interactions Require a Med Change May 2023
Chart: Comparison of Oral Anticoagulants March 2023
Technician Tutorial: Dispensing Oral Blood Thinners November 2022
Article: Ensure Appropriate DOAC Dosing August 2022
Article: Be Prepared to Treat and Prevent VTE Due to Cancer June 2020
Chart: P-glycoprotein Drug Interactions June 2020
Article: Avoid Overlapping Direct Oral Anticoagulants With Warfarin in Most Cases February 2019
Chart: Bridging Warfarin February 2019
Article: Be Familiar With Acute Marijuana Toxicity...and How to Treat It September 2017
Article: Be Cautious Reducing DOAC Doses Per Package Labeling May 2016
PL Voices: Managing Interactions With Direct Oral Anticoagulants (DOACs) May 2016
  • 1
  • About Us
  • Our Mission
  • Our Team
  • Testimonials
  • Careers
  • Newsroom
  • Products
  • Pharmacist Solutions
  • Prescriber Solutions
  • Hospital Solutions
  • Retail Solutions
  • Group Practice Solutions
  • Support & Policies
  • Contact Us
  • Access Agreement
  • Privacy Policy

The contents of this website are not intended to be a substitute for professional medical advice, diagnosis, or treatment. See additional information.

© Therapeutic Research Center. All Rights Reserved